By Sorhaya Zamor, RN, PMHNP, Doctoral Candidate A New Hope in Dementia Care: Addressing Depression with Spravato Dementia is a progressive...
Medically reviewed by Dr. Daniel Brenner, MD | Board-Certified Psychiatrist, Medical Director at Cambridge Biotherapies, Beverly, MA Introduction: A...
Cambridge Biotherapies is thrilled to announce that Spravato™ (esketamine) – a fast-acting, FDA-approved nasal spray for treatment-resistant...
Introduction to Spravato™ Spravato™ (esketamine) is an FDA-approved treatment for patients with treatment-resistant depression, a condition that has...
Depression is a widespread and challenging mental health condition. Finding the right treatment is crucial for recovery. Two effective options are...
Depression is a challenging condition that affects millions of people worldwide. For those with treatment-resistant depression (TRD), finding...
At Cambridge Biotherapies, we offer both Spravato and ketamine infusions to provide effective treatment options for mental health conditions....
We are excited to announce the launch of our new Spravato (esketamine) treatment at Cambridge Biotherapies, now fully covered by insurance. This...